MX2012007227A - Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo. - Google Patents

Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo.

Info

Publication number
MX2012007227A
MX2012007227A MX2012007227A MX2012007227A MX2012007227A MX 2012007227 A MX2012007227 A MX 2012007227A MX 2012007227 A MX2012007227 A MX 2012007227A MX 2012007227 A MX2012007227 A MX 2012007227A MX 2012007227 A MX2012007227 A MX 2012007227A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
vitamin
analogue
cosolvent
surfactant mixture
Prior art date
Application number
MX2012007227A
Other languages
English (en)
Inventor
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of MX2012007227A publication Critical patent/MX2012007227A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se describe una composición farmacéutica tópica que es una emulsión aceite-en-agua-en-aceite que comprende un derivado o análogo de vitamina D disuelto en una mezcla de un tensioactivo no iónico y un alcanol inferior. La composición farmacéutica tópica puede ser utilizada en el tratamiento de condiciones dérmicas, tales como la psoriasis.
MX2012007227A 2009-12-22 2009-12-22 Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo. MX2012007227A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (en) 2009-12-22 2009-12-22 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Publications (1)

Publication Number Publication Date
MX2012007227A true MX2012007227A (es) 2012-07-30

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012007227A MX2012007227A (es) 2009-12-22 2009-12-22 Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo.

Country Status (13)

Country Link
EP (1) EP2515912A4 (es)
JP (1) JP5548275B2 (es)
CN (1) CN102770143B (es)
AU (1) AU2009357263B2 (es)
BR (1) BR112012015447A2 (es)
CA (1) CA2785249A1 (es)
HK (1) HK1177695A1 (es)
IL (1) IL220513A (es)
MX (1) MX2012007227A (es)
NZ (1) NZ601002A (es)
RU (1) RU2500387C1 (es)
WO (1) WO2011076206A1 (es)
ZA (1) ZA201204619B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106344589B (zh) * 2016-11-10 2019-11-26 江苏知原药业有限公司 一种稳定性改善的卡泊三醇倍他米松组合物
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
US20230225970A1 (en) * 2020-08-26 2023-07-20 Canadian Nano Pharmaceutical Technology Inc. Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
CN115350151B (zh) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 一种高稳定性阿法骨化醇液体口服制剂及其制备方法
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39706E1 (en) * 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
JP3340310B2 (ja) * 1996-03-28 2002-11-05 株式会社資生堂 複合エマルジョンおよびその製造方法
JP4511639B2 (ja) * 1997-12-09 2010-07-28 中外製薬株式会社 ビタミンｄ３誘導体を含有するクリーム剤
US6372233B1 (en) * 1997-12-09 2002-04-16 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin D3 derivatives
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
NZ515138A (en) * 1999-04-23 2003-10-31 Leo Pharm Prod Ltd Vitamin D analogues and their pharmaceutical use
JP2001025359A (ja) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp Ｏ／ｗ／ｏ型エマルジョン組成物およびその製造方法
CA2610755A1 (en) * 2005-06-10 2006-12-14 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
FR2893847B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
JP4913487B2 (ja) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 使用感に特徴のある化粧料
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2911781B1 (fr) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid

Also Published As

Publication number Publication date
NZ601002A (en) 2014-09-26
HK1177695A1 (en) 2013-08-30
AU2009357263B2 (en) 2015-04-09
ZA201204619B (en) 2013-09-25
CN102770143B (zh) 2014-11-05
CA2785249A1 (en) 2011-06-30
JP5548275B2 (ja) 2014-07-16
EP2515912A4 (en) 2013-12-25
IL220513A0 (en) 2012-08-30
IL220513A (en) 2016-05-31
WO2011076206A1 (en) 2011-06-30
BR112012015447A2 (pt) 2016-03-15
EP2515912A1 (en) 2012-10-31
RU2500387C1 (ru) 2013-12-10
AU2009357263A1 (en) 2012-07-19
JP2013515017A (ja) 2013-05-02
CN102770143A (zh) 2012-11-07

Similar Documents

Publication Publication Date Title
MX2012007227A (es) Composicion farmaceutica que comprende analogo de vitamina d y mezcla de cosolvente-tensioactivo.
AU2018236800B2 (en) DNA-PK inhibitors
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
EA201290596A1 (ru) Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице
MX2009010170A (es) Formulaciones topicas que tienen biodisponibilidad aumentada.
CU20130069A7 (es) Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis
MX2011011514A (es) Formulaciones de canabidiol y metodos para utilizarlas.
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
CL2007001972A1 (es) Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metilpiridin-3-ilamino)-5-metilpirimidin-4-iloxi]piperidin-1-carboxilico, moduladores del metabolismo; composicion farmaceutica; y su uso para tratar trastornos metabolicos.
WO2012177757A3 (en) Personal care compositions comprising shaped abrasive particles
MX2012003555A (es) Composicion farmaceutica que comprende acido graso omega-3 y derivado hidroxi de una estatina y metodos para usar la misma.
BR112013018352A2 (pt) composição de minociclina tópica e método
EP4306168A3 (en) Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2013093823A3 (en) Topical oil composition for the treatment of fungal infections
MX2014006947A (es) Composiciones antimicrobianas que comprenden dgla, 15-ohepa y/o 15-hetre y metodos de uso de las mismas.
MX2012007229A (es) Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
CL2014002591A1 (es) Composicion topica semisolida que comprende pirfenidona, dialil oxido de disulfuro modificado (odd-m), un agente gelificante y otros excipientes o aditivos; proceso para fabricarla; metodo de tratamiento; y su uso para eliminar, reducir o prevenir el acne.
PH12014500859A1 (en) Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
MX2012007225A (es) Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d.
MX2010010345A (es) Composiciones oftalmicas topicas mejoradas.
MY160377A (en) Topical pharmaceutical compositions
MY171526A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof

Legal Events

Date Code Title Description
FG Grant or registration